ADAM15 and breast cancer: To better understand how ADAM15 isoforms affect breast cancer prognosis, we have established two isogenic cell panels expressing individual ADAM15 isoforms in either the aggressive triple negative breast cancer cell line MDA-MB-231 or the less aggressive MCF7 cell line utilising the Invitrogen FLP-in system.